First-in-Human Use of a Retention-Enhanced Catheter for Endomyocardial Cell Delivery

Warren Sherman,Jozef Bartunek,Dariouch Dolatabadi,Ricardo Sanz-Ruiz,Branko Beleslin,Wojtek Wojakowski,Guy R. Heyndrickx,Jose Zefu Kimpalou,Scott A. Waldman,Gerrit J. Laarman,Aymeric Seron,Atta Behfar,Jean-Pierre Latere,Andre Terzic,William Wijns,Chart Program

First-in-Human Use of a Retention-Enhanced Catheter for Endomyocardial Cell Delivery

2018

Warren Sherman
Jozef Bartunek
Dariouch Dolatabadi
Ricardo Sanz-Ruiz
Branko Beleslin
Wojtek Wojakowski
Guy R. Heyndrickx
Jose Zefu Kimpalou
Scott A. Waldman
Gerrit J. Laarman
Aymeric Seron
Atta Behfar
Jean-Pierre Latere
Andre Terzic
William Wijns
Chart Program

A novel deflectable-tip catheter (C-Cathez, Celyad, Mont-Saint-Guibert, Belgium) featuring a curved needle containing side holes developed to increase the retention of intramyocardial biotherapeutics [(1)][1] underwent first-in-human use in the CHART-1 (Congestive Heart Failure Cardiopoietic

Keywords:

Cardiology
Internal medicine
Catheter
Heart failure
Medicine
cell delivery
first in human

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations